K
Kefeng Dou
Researcher at Fourth Military Medical University
Publications - 71
Citations - 3566
Kefeng Dou is an academic researcher from Fourth Military Medical University. The author has contributed to research in topics: Hepatocellular carcinoma & Transplantation. The author has an hindex of 26, co-authored 65 publications receiving 2797 citations.
Papers
More filters
Journal ArticleDOI
Circular RNA: A new star of noncoding RNAs
Shibin Qu,Xisheng Yang,Xiaolei Li,Jianlin Wang,Yuan Gao,Runze Shang,Wei Sun,Kefeng Dou,Haimin Li +8 more
TL;DR: Similar to miRNAs and long noncoding RNAs (lncRNAs), circRNAs are becoming a new research hotspot in the field of RNA and could be widely involved in the processes of life.
Journal ArticleDOI
Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
Zhuochao Zhang,Xiao Li,Wei Sun,Shuqiang Yue,Jing-Yue Yang,Junjie Li,Ben Ma,Jianlin Wang,Xisheng Yang,Meng Pu,Bai Ruan,Ge Zhao,Qike Huang,Lin Wang,Kaishan Tao,Kefeng Dou +15 more
TL;DR: Data suggest that CAF-mediated HCC tumour progression is partially related to the loss of antitumour miR-320a in the exosomes of CAFs and that promoting the transfer of stromal cell-derived miR -320a might be a potential treatment option to overcome HCC progression.
Journal ArticleDOI
Evaluation of sorafenib in Chinese unresectable hepatocellular carcinoma patients with prior surgery and portal vein tumor thrombosis: A subset analysis of GIDEON study data.
Sheng Long Ye,Xiaoping Chen,Jiamei Yang,Ping Bie,Shuijun Zhang,Fengyong Liu,Luming Liu,Jie Zhou,Kefeng Dou,Christina S.M. Yip,Xiaolei Yang +10 more
TL;DR: It is concluded that earlier administration of sorafenib may result in improved outcomes in patients with unresectable hepatocellular carcinoma and portal vein tumor thrombosis.
Journal ArticleDOI
MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.
Fan Yang,Qing-jun Li,Zhen-bin Gong,Liang Zhou,Nan You,Su Wang,Xiao-lei Li,Junjie Li,Jiaze An,Desheng Wang,Yong He,Kefeng Dou +11 more
TL;DR: This study is the first to demonstrate that miR-34a induces sensitivity to the anti-tumor effect of sorafenib in human HCC cells, suggesting a potential role of miR -34a in the treatment of HCC.
Journal ArticleDOI
Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis
Wei Zhao,Junjie Li,Da-Yong Cao,Li Xiao,Lin-Ying Zhang,Yong He,Shu-Qiang Yue,Desheng Wang,Kefeng Dou +8 more
TL;DR: The results of histopathological staining, immunohistochemistry, and biochemical analysis indicated that intravenous injection is more effective at rescuing liver failure than other injection modalities.